These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30142860)

  • 21. Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
    Zenke Y; Ishii G; Ohe Y; Kaseda K; Yoshida T; Matsumoto S; Umemura S; Yoh K; Niho S; Goto K; Ohmatsu H; Kuwata T; Nagai K; Ochiai A
    Pathol Int; 2013 Dec; 63(12):599-606. PubMed ID: 24422956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women.
    Schwartz T; Stark A; Pang J; Awuah B; Kleer CG; Quayson S; Kingman S; Aitpillah F; Abantanga F; Jiagge E; Oppong JK; Osei-Bonsu E; Martin I; Yan X; Toy K; Adjei E; Wicha M; Newman LA
    Cancer; 2013 Feb; 119(3):488-94. PubMed ID: 22930220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
    Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
    Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldehyde dehydrogenase 1 expression is a predictor of poor prognosis in node-positive breast cancers: a long-term follow-up study.
    Yoshioka T; Umekita Y; Ohi Y; Souda M; Sagara Y; Sagara Y; Sagara Y; Rai Y; Tanimoto A
    Histopathology; 2011 Mar; 58(4):608-16. PubMed ID: 21371077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ALDH1 expression correlates with favorable prognosis in ovarian cancers.
    Chang B; Liu G; Xue F; Rosen DG; Xiao L; Wang X; Liu J
    Mod Pathol; 2009 Jun; 22(6):817-23. PubMed ID: 19329942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.
    DA Cruz Paula A; Marques O; Rosa AM; DE Fátima Faria M; Rêma A; Lopes C
    Anticancer Res; 2014 Mar; 34(3):1427-34. PubMed ID: 24596390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
    Chatterjee D; Bal A; Das A; Singh G
    Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffuse optical spectroscopy for monitoring the responses of patients with breast cancer to neoadjuvant chemotherapy: A meta-analysis.
    Liu YH; Xue LB; Yang YF; Zhao TJ; Bai Y; Zhang BY; Li J
    Medicine (Baltimore); 2018 Oct; 97(41):e12683. PubMed ID: 30313063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer.
    Papadaki MA; Kallergi G; Zafeiriou Z; Manouras L; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
    BMC Cancer; 2014 Sep; 14():651. PubMed ID: 25182808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
    Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
    Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
    Gao ZH; Li CX; Liu M; Jiang JY
    BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
    Heerma van Voss MR; van der Groep P; Bart J; van der Wall E; van Diest PJ
    Cell Oncol (Dordr); 2011 Feb; 34(1):3-10. PubMed ID: 21336637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies.
    Tao Y; Li H; Huang R; Mo D; Zeng T; Fang M; Li M
    Cell Physiol Biochem; 2018; 46(4):1716-1726. PubMed ID: 29730663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival benefit of neoadjuvant chemotherapy for resectable breast cancer: A meta-analysis.
    Chen Y; Shi XE; Tian JH; Yang XJ; Wang YF; Yang KH
    Medicine (Baltimore); 2018 May; 97(20):e10634. PubMed ID: 29768327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased aldehyde dehydrogenase 1 (ALDH1) levels are associated with chemo-responsiveness in breast cancer patients treated with taxane-adriamycin-cyclophosphamide regimen.
    Hapidah H; Djabir YY; Prihantono P
    Breast Dis; 2021; 40(S1):S33-S37. PubMed ID: 34057116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of
    Han S; Choi JY
    Breast Cancer Res; 2020 Oct; 22(1):119. PubMed ID: 33129348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis.
    Zhou C; Sun B
    Oral Oncol; 2014 Dec; 50(12):1144-8. PubMed ID: 25264224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
    Knudsen ES; Dervishaj O; Kleer CG; Pajak T; Schwartz GF; Witkiewicz AK
    Cell Cycle; 2013 Jul; 12(13):2042-50. PubMed ID: 23759596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.